Superbugs & Superdrugs conference
London, GB (March, 20 - 21, 2017)
Expanding horizons on the growing threat of
anti-microbial resistance for almost two decades, the flagship show in the
global Superbugs portfolio of events will once again play host to an
international audience of scientific leaders, funding bodies and drug discovery
specialists, providing a focal point to push industry collaboration through
updates on clinical advancements and investment opportunities.
Each year, around 2 million people are taken ill in the US from
antibiotic-resistant bacteria and kills at least 23,000, according to estimates
by the Centers for Disease Control and Prevention. The threat is so high that
in September 2014 President Barack Obama issued an executive order Combating
Antibiotic-Resistant Bacteria. *
The threat is the same in Europe, big pharmaceutical companies are re-entering
the space into development of new antibiotics after decades. In January 2016,
more than 80 pharmaceutical, biotechnology and diagnostics companies including
Roche, Pfizer, Novartis AG and GlaxoSmithKline pledged at the World Economic
Forum to fight the threat of antimicrobial resistance.*
The industry’s premier event on antibiotic resistance will provide a perfect
platform for its growing "superbugs" community to network, exchange
novel solutions and consolidate current strategies. A must attend for both new and seasoned
stakeholders involved in AMR and infectious disease.
https://www.fredhutch.org/en/news/center-news/2015/01/combating-superbugs-superdrugs-antibiotics.html
http://www.iol.co.za/business/international/big-pharma-drawn-back-to-antibiotics-2040209
PREVIOUS ATTENDEE TESTIMONIALS FROM SUPERBUGS & SUPERDRUGS 2016
- “Great meeting to network and have time to discuss face to face. Key questions and issues. Very collaborative open meeting.” – Roche
- “It was one of the most useful scientific conferences that I have attended” – BARDA
- “Good mix of problems such as funding and novel opportunities and success stories” – TNO
- “I enjoyed attending the meeting this year and wanted to thank you for your efforts in organizing it” – UNT Health Science Centre
- “I like the mix of early stage technologies and also later stage products being presented” – Sempra Pharmaceuticals
More: http://www.smi-online.co.uk/pharmaceuticals/uk/superbugs-superdrugs?ut
